薛妍, 刘海燕. 核医学分子影像在卵巢癌诊疗中的应用[J]. 国际放射医学核医学杂志, 2023, 47(12): 774-780. DOI: 10.3760/cma.j.cn121381-202302004-00364
引用本文: 薛妍, 刘海燕. 核医学分子影像在卵巢癌诊疗中的应用[J]. 国际放射医学核医学杂志, 2023, 47(12): 774-780. DOI: 10.3760/cma.j.cn121381-202302004-00364
Yan Xue, Haiyan Liu. Application of nuclear medicine molecular imaging in the diagnosis and treatment of ovarian cancer[J]. Int J Radiat Med Nucl Med, 2023, 47(12): 774-780. DOI: 10.3760/cma.j.cn121381-202302004-00364
Citation: Yan Xue, Haiyan Liu. Application of nuclear medicine molecular imaging in the diagnosis and treatment of ovarian cancer[J]. Int J Radiat Med Nucl Med, 2023, 47(12): 774-780. DOI: 10.3760/cma.j.cn121381-202302004-00364

核医学分子影像在卵巢癌诊疗中的应用

Application of nuclear medicine molecular imaging in the diagnosis and treatment of ovarian cancer

  • 摘要: 卵巢癌是女性生殖系统常见的恶性肿瘤之一,早期诊断困难,初次治疗后容易复发,预后较差,其诊疗仍面临着巨大挑战。影像学在卵巢癌的诊疗中是不可或缺的重要组成部分。其中,核医学分子影像技术已经成为卵巢癌诊疗中极具潜力的非侵入性显像手段。PET/CT在卵巢癌的诊断、分期、治疗疗效、预后及复发的评估中应用广泛;PET/MRI因其较高的软组织分辨率和较低的辐射剂量,在卵巢癌诊疗中表现出较大的优势;SPECT/CT也因多种新型放射性示踪剂的研发而在卵巢癌的诊疗中发挥着重要作用。笔者就PET/CT、PET/MRI及SPECT/CT在卵巢癌中的应用及研究进展进行综述,以期进一步提高分子影像技术在卵巢癌诊疗中的价值。

     

    Abstract: Ovarian cancer is one of the common malignant tumors of female reproductive system. It is difficult to diagnose early, prone to relapse after initial treatment, and has a poor prognosis, so diagnosis and treatment still face great challenges. Imaging examination is an indispensable part in the diagnosis and treatment of ovarian cancer. Among them, nuclear medicine molecular imaging technology has become a highly potential non-invasive imaging method in the diagnosis and treatment of ovarian cancer. PET/CT has been widely used in the diagnosis, staging, treatment efficacy, prognosis, and recurrence evaluation of ovarian cancer. PET/MRI has shown significant advantages in the diagnosis and treatment of ovarian cancer due to its high soft tissue resolution and low radiation dose. SPECT/CT also plays an important role in the diagnosis and treatment of ovarian cancer due to the development of various new radioactive tracers. The authors review the application and research progress of PET/CT, PET/MRI and SPECT/CT about ovarian cancer, in order to further improve the value of molecular imaging technology in the diagnosis and treatment of ovarian cancer.

     

/

返回文章
返回